P

Pulmatrix

D
PULM
USD
1.56
(78%)
Market Closed
41,719.00
Volume
-4.5
EPS
-
Div Yield
-1.171141
P/E
13,002,134.60
Market Cap
Today
78.0000%
1 Week
67.136%
1 Month
72.816%
6 Months
95.604%
12 Months
97.230%
Year To Date
89.362%
All Time
0%

Title:
Pulmatrix

Sector:
Healthcare
Industry:
Biotechnology
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmetmedical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.
Do you need help or have a question?